Qualitic
Startup developing a rapid, low-cost paper-based screening test for Clostridioides difficile intended for point-of-care use. Work includes assay and device development, early-stage testing, academic and hospital partnerships, NIH-sponsored research, and plans for clinical trials and regulatory submission.
Industries
Nr. of Employees
small (1-50)
Products
Rapid paper-based C. difficile screening card
A paper-based screening card that uses an oxidation–reduction color change to indicate presence of C. difficile; designed for point-of-care use without laboratory equipment and with a visual readout in under one minute.
Rapid paper-based C. difficile screening card
A paper-based screening card that uses an oxidation–reduction color change to indicate presence of C. difficile; designed for point-of-care use without laboratory equipment and with a visual readout in under one minute.
Services
Clinical trial collaboration and research partnerships
Partnerships with hospitals and academic centers to run clinical studies and gather evidence for the screening device.
Research funding and grant-supported project execution
Management of grant-funded research projects, including NIH-sponsored work and preparation for additional grant applications.
Clinical trial collaboration and research partnerships
Partnerships with hospitals and academic centers to run clinical studies and gather evidence for the screening device.
Research funding and grant-supported project execution
Management of grant-funded research projects, including NIH-sponsored work and preparation for additional grant applications.
Expertise Areas
- Point-of-care diagnostic development
- Assay development and optimization
- Clinical trial planning and hospital partnerships
- Infectious disease diagnostics (C. difficile)
Key Technologies
- Paper-based colorimetric assays
- Oxidation–reduction colorimetric chemistry
- Point-of-care rapid diagnostics (equipment-free)
- Low-resource diagnostic design